Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Clinical trial NCT00751205 · COMPLETED

Trial details

NCT number: NCT00751205
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Ovarian Cancer

Start date: 2008-08-01
Primary completion: 2010-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.